Sanofi-aventis has an 85-year track record of commitment to developing effective solutions for diabetes patients. Faced with the public health challenge that the worldwide diabetes epidemic represents, sanofi-aventis delivers innovative, patient-centred care options. Sanofi-aventis has products available for people with type 1 or type 2 diabetes, and is researching, developing and bringing new services and products to market to assist Australians in effectively managing their own health.
Click here for information on how to join APEG